Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M GILSON

Showing results (31-40 of 172) with videos related to

Pageof 18
Sort By:
Pain Medicine (Malden, Mass.)|February 20, 2007
A much-needed window on opioid diversionDavid E Joranson, Aaron M Gilson
Journal of Pain & Palliative Care Pharmacotherapy|December 2, 2008
Is the DEA's new "prescription series" regulation balanced?Aaron M Gilson, David E Joranson
Pain Medicine (Malden, Mass.)|May 8, 2010
Commentary to Michna et al.: The elephant in the room: hydrocodone/acetaminophen combination compounds and the substitution effectScott M Fishman, Aaron M Gilson
Pharmacoepidemiology and Drug Safety|July 25, 2006
Wanted: a public health approach to prescription opioid abuse and diversionDavid E Joranson, Aaron M Gilson
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|April 12, 2001
Pharmacists' knowledge of and attitudes toward opioid pain medications in relation to federal and state policiesD E Joranson, A M Gilson
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|January 1, 1994
Policy issues and imperatives in the use of opioids to treat pain in substance abusersD E Joranson, A M Gilson
Biochimica Et Biophysica Acta|December 2, 1988
Assembly of Rubisco from native subunitsH Roy, S Cannon, M Gilson
Journal of Pain & Palliative Care Pharmacotherapy|November 23, 2007
The federal Drug Enforcement Administration "prescription series" proposal: continuing concernsAaron M Gilson, David E Joranson
Pain Medicine (Malden, Mass.)|October 28, 2008
DEA: revisitedHoward A Heit, Aaron M Gilson
Journal D'Urologie Medicale Et Chirurgicale|October 29, 2010
A type of progression from renal tuberculosisG WOLFROMM, A CAILLERET, M GILSON
Pageof 18

Showing results (31-40 of 172) with videos related to

Sort By:
Pageof 18
Pain Medicine (Malden, Mass.)|February 20, 2007
A much-needed window on opioid diversionDavid E Joranson, Aaron M Gilson
Journal of Pain & Palliative Care Pharmacotherapy|December 2, 2008
Is the DEA's new "prescription series" regulation balanced?Aaron M Gilson, David E Joranson
Pain Medicine (Malden, Mass.)|May 8, 2010
Commentary to Michna et al.: The elephant in the room: hydrocodone/acetaminophen combination compounds and the substitution effectScott M Fishman, Aaron M Gilson
Pharmacoepidemiology and Drug Safety|July 25, 2006
Wanted: a public health approach to prescription opioid abuse and diversionDavid E Joranson, Aaron M Gilson
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|April 12, 2001
Pharmacists' knowledge of and attitudes toward opioid pain medications in relation to federal and state policiesD E Joranson, A M Gilson
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|January 1, 1994
Policy issues and imperatives in the use of opioids to treat pain in substance abusersD E Joranson, A M Gilson
Biochimica Et Biophysica Acta|December 2, 1988
Assembly of Rubisco from native subunitsH Roy, S Cannon, M Gilson
Journal of Pain & Palliative Care Pharmacotherapy|November 23, 2007
The federal Drug Enforcement Administration "prescription series" proposal: continuing concernsAaron M Gilson, David E Joranson
Pain Medicine (Malden, Mass.)|October 28, 2008
DEA: revisitedHoward A Heit, Aaron M Gilson
Journal D'Urologie Medicale Et Chirurgicale|October 29, 2010
A type of progression from renal tuberculosisG WOLFROMM, A CAILLERET, M GILSON
Pageof 18